Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a subscription agreement with entities associated with TCGX, an institutional...